Could

Ghislaine Maxwell’s conviction could spell trouble for Prince Andrew

Virginia Giuffre is suing the monarch's middle son for allegedly sexually assaulting her when she was 17

Top Mitch McConnell Staffer Leads Pfizer’s Lobbying Charge to Protect Vaccine Patent and Block Bill Holding Big Pharma Accountable for Fraud.

Pfizer has hired the former policy director for Senate Minority Leader Mitch McConnell, Hazen Marshall, as a lobbyist to support the Big Pharma firm’s efforts to shut down amendments to the False Claims Amendments Act of 2021. The lobbying contract covers opposition to whistleblower protections and affirming Pfizer’s patents on the COVID-19 vaccine, The National Pulse can reveal.

Legal scholar Turley asks why hasn’t FBI raided NY Times publisher, as with O’Keefe

"Sulzberger really had no reason to worry even after the O’Keefe raid," Turley argues. "That is precisely the problem."

Fauci Says Yet Another COVID Vax Could Be Needed on Top of Booster

Dr. Anthony Fauci says it is “conceivable” that people could need another COVID vaccine on top of their current booster.

W.H.O. Director Says COVID Could Be ‘Fully Resistant’ to Vax

New coronavirus variants could “become fully resistant to current vaccines or past infection,” says the head of the World Health Organization (WHO).

First Maxwell, Now Prince Andrew? New Legal Development Could Mean Big Trouble for Epstein-Linked Royal

On the same day a jury convicted disgraced socialite Ghislaine Maxwell on five of six counts of sex trafficking related to her former lover Jeffrey Epstein, another Epstein associate received ominous legal news.

Trump legal team says Thompson’s comments reveal real reason behind Jan. 6 committee

Former President Donald Trump is banking on a Washington Post interview with the chairman of the House committee investigating the Jan. 6 attack on the Capitol to back a key claim in his case before the Supreme Court.

Joe Biden Denies Monoclonal Antibody Treatments as States Experience Shortages

President Joe Biden continues ignoring state demands for more monoclonal antibody treatments, as shortages are preventing Americans seeking the treatment from accessing them.

The GOP Will Probably Win In 2022, But It Won’t Be Enough

The GOP has a lot to look forward to, electorally speaking, heading into the 2022 midterms.

Latest news

- Advertisement -spot_img